Evidence map›Paper›PMID 33459908›Full record

ArticleClinical and experimental nephrology2021

Effects of phospholipase A

Hasan H Yeter, Ipek Isik Gonul, Esra Eraslan, Ceren Karacalik, Betul Ogut, Galip Guz

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hasan H YeterDepartment of Nephrology Dialysis and Transplantation, Gazi University Faculty of Medicine, 06560, Ankara, Turkey. hasanyeter@hotmail.com.ORCID http://orcid.org/0000-0002-5787-1048
Ipek Isik GonulDepartment of Pathology, Gazi University Faculty of Medicine, 06560, Ankara, Turkey.
Esra EraslanDepartment of Internal Medicine, Gazi University Faculty of Medicine, 06560, Ankara, Turkey.
Ceren KaracalikDepartment of Internal Medicine, Gazi University Faculty of Medicine, 06560, Ankara, Turkey.
Betul OgutDepartment of Pathology, Gazi University Faculty of Medicine, 06560, Ankara, Turkey.
Galip GuzDepartment of Nephrology Dialysis and Transplantation, Gazi University Faculty of Medicine, 06560, Ankara, Turkey.
Gazi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to define the clinicopathologic features of phospholipase A

methodsA total of 201 patients were enrolled for baseline clinical and histopathological features and 102 patients with a clinical follow-up for more than 1 year were evaluated for outcomes. Immunohistochemical staining was performed with PLA

resultsPLA

conclusionsThe probability of achieving complete remission is high in patients with PLA

Indexed as

AdultBiopsyDisease ProgressionFemaleGlomerular Basement MembraneGlomerular Filtration RateGlomerulonephritis, MembranousHumansImmunoglobulin GImmunosuppressive AgentsMaleMiddle AgedProportional Hazards ModelsReceptors, Phospholipase A2RecurrenceRetrospective StudiesImmunoglobulin GImmunosuppressive AgentsReceptors, Phospholipase A2ThrombospondinsTHSD7A protein, humanMembranous nephropathyOutcomePhospholipase A2 receptorRelapseThrombospondin type-1 domain-containing 7A

Identifiers

PMID33459908
OpenAlexW3122760997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.